Quantcast

Latest Percutaneous coronary intervention Stories

2014-07-09 16:28:44

BASKING RIDGE, N.J., July 9, 2014 /PRNewswire/ -- Regado Biosciences, Inc., (NASDAQ: RGDO) today announced that, further to their decision to voluntarily pause enrollment in their REGULATE-PCI trial, the United States Food and Drug Administration (FDA) informed the company today that a clinical hold has been placed on all patient enrollment and dosing of either study drug in the ongoing Phase 3 REGULATE-PCI trial. According to the FDA, this action was taken to formalize the...

2014-07-09 12:30:56

Efforts to Reduce Overstenting and Price Competition Will Somewhat Restrict Market Expansion, According to Findings from Decision Resources Group BURLINGTON, Mass., July 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for interventional cardiology (IC) devices still holds considerable potential for growth in the Asia Pacific, despite stagnating in recent years in the United States and Europe. This is particularly true in China and India, where expanding economies are...

2014-07-07 09:40:29

The Lancet A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment. The study suggests that use of one of the drugs, heparin, could result in improved outcomes (such as a reduced rate of repeat heart attacks), compared to the other drug tested, bivalirudin, which is in widespread use in high-income countries, and is around 400 times more expensive than heparin. The results of the HEAT-PPCI trial...

2014-07-07 08:26:15

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018http://www.reportbuyer.com/pharma_healthcare/medical_devices/coronary_stents_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.htmlGlobal Market Watch:BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by...

2014-07-03 23:00:23

LifeScienceIndustryResearch.com offers "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft – Forecast to 2018" research report in its store. Dallas, TX (PRWEB) July 04, 2014 The North American interventional cardiology and peripheral vascular devices market is expected to grow at a CAGR of 2.9%...

2014-07-03 12:25:12

DALLAS, July 3, 2014 /PRNewswire/ -- Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018 market research report says global interventional cardiology market is estimated to reach US$22.2 billion by 2016. This report published in June 2014 is spread across 798 pages. The report consists of 375 data charts describing the market shares, sales forecasts and growth prospects. Global Interventional Cardiac Devices market is...

2014-07-02 20:21:45

BASKING RIDGE, N.J., July 2, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the Phase 3 clinical development of Revolixys(TM) Kit (previously known as REG1), its first-in-class, actively controllable antithrombotic drug system, today announced that the Data Safety Monitoring Board (DSMB) has initiated an unplanned review of data from the REGULATE-PCI trial. Patient enrollment has been paused until the DSMB has completed its...

2014-06-24 08:32:14

Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 BIO International Convention on a pre-specified interim analysis from its international ASPIRE Phase 3 registration clinical study of Generx(®) Ad5FGF-4, Cardium Therapeutics' angiogenic gene...

2014-06-23 08:27:50

Phase 1 Clinical Data Highlights Factor IXa as an Excellent Target for Anticoagulation Therapy BASKING RIDGE, N.J., June 23, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the discovery and development of actively controllable aptamer therapeutics for the acute care setting, today announced the publication in the Journal of Thrombosis and Thrombolysis of data from a single escalating-dose Phase 1 clinical trial of the REG2...

2014-06-11 23:02:28

ReportsnReports.com adds “North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018” reports to its research database. Dallas, Texas (PRWEB) June 11, 2014 The North American Interventional cardiology and peripheral vascular devices market are expected to grow at a CAGR of 2.9% from 2013 to...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.